Abstract
Current Pharmaceutical Design
Title: Editorial [Hot Topic: Ion Channels as a Target for Drug Design )Executive Editor: Kwok-Keung Tai)]
Volume: 11 Issue: 21
Author(s): Kwok-Keung Tai
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Tai Kwok-Keung, Editorial [Hot Topic: Ion Channels as a Target for Drug Design )Executive Editor: Kwok-Keung Tai)], Current Pharmaceutical Design 2005; 11 (21) . https://dx.doi.org/10.2174/1381612054546860
DOI https://dx.doi.org/10.2174/1381612054546860 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacotherapy of Borderline Personality Disorder: A Systematic Review
Current Medicinal Chemistry Triggers of Cell Death in the Developing Brain
Current Pediatric Reviews Clinical Studies with Targeted Toxins in Malignant Glioma
Reviews on Recent Clinical Trials 2-Arylindoles: A Privileged Molecular Scaffold with Potent, Broad-Ranging Pharmacological Activity
Current Medicinal Chemistry Mesenchymal Stem Cells Targeting of Systemic Disorders in Age-related Macular Degeneration
Current Tissue Engineering (Discontinued) Role of Cation-Chloride-Cotransporters (CCC) in Pain and Hyperalgesia
Current Topics in Medicinal Chemistry Whole Embryo Culture: An Important Tool in Developmental Toxicology Today
Current Pharmaceutical Design Modulation of the Basal Ganglia by Metabotropic Glutamate Receptors: Potential for Novel Therapeutics
Current Drug Targets - CNS & Neurological Disorders Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Meet Our Editorial Board Member
Current Neuropharmacology Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Could Better Phenotyping Small Vessel Disease Provide New Insights into Alzheimer Disease and Improve Clinical Trial Outcomes?
Current Alzheimer Research Development of Radioligands for In Vivo Imaging of Type 1 Cannabinoid Receptors (CB1) in Human Brain
Current Pharmaceutical Design Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside
Current Neuropharmacology The Beneficial Effect of Rice Bran Extract Against Rotenone-Induced Experimental Parkinson’s Disease in Rats
Current Molecular Pharmacology What have Genetically Engineered Mice Taught Us About Ischemic Injury?
Current Molecular Medicine Analysis of Adverse Events Related to 720 Cases of Neural Progenitor Cell Transplantation
CNS & Neurological Disorders - Drug Targets Drug Trials in Dementia: Challenging Ethical Dilemmas
Current Alzheimer Research Meet Our Editorial Board Member
Current Neuropharmacology